Fa-Chyi Lee

2.3k total citations
24 papers, 385 citations indexed

About

Fa-Chyi Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Fa-Chyi Lee has authored 24 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Fa-Chyi Lee's work include Colorectal Cancer Treatments and Studies (8 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). Fa-Chyi Lee is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). Fa-Chyi Lee collaborates with scholars based in United States, Switzerland and Netherlands. Fa-Chyi Lee's co-authors include Daniel C. Rabe, Manish A. Shah, Howard Kallender, Harold Keer, Li Liu, Donald P. Bottaro, Peter L. Bonate, Zev A. Wainberg, Daniel V.T. Catenacci and Yuan Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Fa-Chyi Lee

22 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fa-Chyi Lee United States 9 193 156 124 85 79 24 385
Susanne Hedbom Germany 4 277 1.4× 120 0.8× 167 1.3× 82 1.0× 47 0.6× 5 463
Marco Imperatori Italy 10 273 1.4× 121 0.8× 111 0.9× 62 0.7× 75 0.9× 13 424
Gunta Purkalne Latvia 12 183 0.9× 119 0.8× 151 1.2× 37 0.4× 32 0.4× 31 425
Eric Xueyu Chen Canada 9 187 1.0× 85 0.5× 126 1.0× 48 0.6× 67 0.8× 54 370
Yong Mun United States 11 313 1.6× 115 0.7× 132 1.1× 50 0.6× 79 1.0× 43 464
Geoff Chong Australia 9 274 1.4× 117 0.8× 64 0.5× 37 0.4× 111 1.4× 25 414
Jayne Gurtler United States 7 188 1.0× 98 0.6× 68 0.5× 120 1.4× 82 1.0× 14 332
Eleni Vrettou Greece 15 304 1.6× 113 0.7× 147 1.2× 145 1.7× 119 1.5× 33 562
Meaghan Dendy United States 8 105 0.5× 60 0.4× 200 1.6× 89 1.0× 38 0.5× 11 345

Countries citing papers authored by Fa-Chyi Lee

Since Specialization
Citations

This map shows the geographic impact of Fa-Chyi Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fa-Chyi Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fa-Chyi Lee more than expected).

Fields of papers citing papers by Fa-Chyi Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fa-Chyi Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fa-Chyi Lee. The network helps show where Fa-Chyi Lee may publish in the future.

Co-authorship network of co-authors of Fa-Chyi Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Fa-Chyi Lee. A scholar is included among the top collaborators of Fa-Chyi Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fa-Chyi Lee. Fa-Chyi Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Fa-Chyi, et al.. (2024). A case report of challenges in distinguishing gastroesophageal junction hepatoid adenocarcinoma from testicular germ cell tumor: Insights for improved diagnosis with gene expression profiling. SHILAP Revista de lepidopterología. 12. 2050313X231223469–2050313X231223469. 1 indexed citations
2.
3.
Chen, Wen‐Pin, Christine E. McLaren, Kathryn Osann, et al.. (2024). Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer. Journal of the National Comprehensive Cancer Network. 22(5). 299–305. 3 indexed citations
4.
5.
Lee, Fa-Chyi, et al.. (2023). Case Report: A complete pathologic response in pancreatic cancer with squamous cell differentiation. Frontiers in Oncology. 13. 1240405–1240405.
6.
Dayyani, Farshid, et al.. (2022). BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms. Cancers. 14(10). 2453–2453. 17 indexed citations
7.
Ragavan, Meera Vimala, et al.. (2021). Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems. JCO Oncology Practice. 17(10). e1450–e1459. 15 indexed citations
8.
Lee, Amy & Fa-Chyi Lee. (2019). Medical oncology management of advanced hepatocellular carcinoma 2019: a reality check. Frontiers of Medicine. 14(3). 273–283. 8 indexed citations
9.
Parikh, Aparna R., Fa-Chyi Lee, Linda Yau, et al.. (2018). MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer. Clinical Cancer Research. 25(10). 2988–2995. 39 indexed citations
10.
Lenz, Heinz‐Josef, Fa-Chyi Lee, Linda Yau, et al.. (2016). MAVERICC, a phase 2 study of mFOLFOX6-bevacizumab (BV) vs FOLFIRI-BV with biomarker stratification as first-line (1L) chemotherapy (CT) in patients (pts) with metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 34(4_suppl). 493–493. 26 indexed citations
11.
Bauman, Julie E., Claire F. Verschraegen, Steven A. Belinsky, et al.. (2014). A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers. Translational Oncology. 7(3). 349–354. 28 indexed citations
12.
Murad, Waheed, Ian Rabinowitz, & Fa-Chyi Lee. (2014). Sorafenib-Induced Grade Four Hepatotoxicity in a Patient with Recurrent Gastrointestinal Stromal Tumor (GIST): A Case Report and Review of Literature. ACG Case Reports Journal. 1(2). 115–117. 7 indexed citations
13.
Picozzi, Vincent J., Ramesh K. Ramanathan, Maeve A. Lowery, et al.. (2014). Feasibility and results of a randomized phase Ιb study of fractionated 90Υ-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having two or more prior therapies.. Journal of Clinical Oncology. 32(15_suppl). 4026–4026. 8 indexed citations
14.
Shah, Manish A., Zev A. Wainberg, Daniel V.T. Catenacci, et al.. (2013). Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer. PLoS ONE. 8(3). e54014–e54014. 182 indexed citations
15.
Rojas‐Hernandez, Cristhiam M., et al.. (2013). Phase II trial of sorafenib (S) and capecitabine (C) for hepatocellular carcinoma (HCC) in cirrhotic patients (pts).. Journal of Clinical Oncology. 31(15_suppl). e15136–e15136. 1 indexed citations
16.
17.
Medina‐Flores, Rafael, et al.. (2010). Primary disseminated central neurocytoma: cytological and MRI evidence of tumor spread prior to surgery. Journal of Neuro-Oncology. 100(2). 291–298. 8 indexed citations
18.
Fekrazad, M. Houman, et al.. (2010). Development of Bronchiolitis Obliterans Organizing Pneumonia With Platinum-Based Chemotherapy for Metastatic Rectal Cancer. Clinical Colorectal Cancer. 9(3). 177–178. 12 indexed citations
19.
Rabinowitz, Ian, Robert J. Telepak, & Fa-Chyi Lee. (2002). Octreotide Scans Are Positive in a Subset of Patients with Hepatocellular Carcinoma. Clinical Nuclear Medicine. 27(7). 499–502. 9 indexed citations
20.
Lee, Fa-Chyi, Ronald T. Mitsuyasu, & Steven A. Miles. (1996). Kaposiʼs sarcoma. AIDS. 10(Supplement). S173–180. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Hedbom Breakdown of academic impact, for papers by Marco Imperatori Breakdown of academic impact, for papers by Gunta Purkalne Breakdown of academic impact, for papers by Eric Xueyu Chen Breakdown of academic impact, for papers by Yong Mun Breakdown of academic impact, for papers by Geoff Chong Breakdown of academic impact, for papers by Jayne Gurtler Breakdown of academic impact, for papers by Eleni Vrettou Breakdown of academic impact, for papers by Meaghan Dendy
Rankless by CCL
2026